About Dako
Dako is a global leader in tissue-based cancer diagnostics. Hospital and research laboratories worldwide use Dako’s reagents, instruments, software and expertise to make accurate diagnoses and determine the most effective treatment for cancer patients. Dako became part of Agilent Technologies in 2012.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of Dako
Similar companies
News about Dako
Here you will find Dako Deutschland GmbH
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Last viewed contents
YES Pharma Services GmbH - Friedrichsdorf, Germany
DAIICHI SANKYO AUSTRIA GmbH - Wien, Austria
Bradmer Pharmaceuticals Inc. - Toronto, Canada
GANZONI GmbH - Memmingen, Germany
NorthSea Therapeutics B.V. - Amsterdam, Netherlands
Nederman Norclean GmbH - Geldern, Germany
msscientific Chromatographie-Handel GmbH - Berlin, Germany
DAIICHI SANKYO EUROPE GmbH - Pfaffenhofen, Germany